Myra has together with Diagnostics for the Real World R&D unit in Cambridge developed SAMBA II HIV test device.
Each year appr. 300000 children get HIV through birth. SAMBA II will make a big difference in the developing world due to a major focus on early detection of the HIV virus in infants. Babies of HIV infected women in primitive conditions, suffers a very high risk of also being infected. This is due to inadequate hygiene and poor health facilities and a fast virus detection can change many lives. With Samba ll a test result determining whether or not the child has HIV virus is obtained within 90min, which also means that preventive treatment can be initiated instantly.